Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.
Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells. Mol Cancer Ther. 2008 May; 7(5):1121-9.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Bone Marrow Cells
Cell Line, Tumor
Cell Proliferation
Fusion Proteins, bcr-abl
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Mice
Mice, Nude
Protein Kinase Inhibitors
Pyrimidines
Stromal Cells
authors with profiles
Richard M. Stone, M.D.
Ellen L. Weisberg, Ph.D.
Arghya Ray, Ph.D.
James Douglas Griffin, M.D.